Ranbaxy Tradefin Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.43 Cr
- Company Age 31 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Ranbaxy Tradefin
Ranbaxy Tradefin Pvt Ltd (RTPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 August 1993 and has a history of 31 years and six months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jugal Gupta and Navneet Gupta serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909WB1993PTC059687
- Company No.
059687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Ranbaxy Tradefin?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jugal Gupta  | Director | 15-Jan-2024 | Current |
| Navneet Gupta | Director | 04-Jan-2007 | Current |
Financial Performance of Ranbaxy Tradefin.
Ranbaxy Tradefin Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ranbaxy Tradefin?
In 2017, Ranbaxy Tradefin had a promoter holding of 26.76% and a public holding of 73.24%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Divine Kitchenware LlpJugal Gupta is a mutual person
Jadabpur Tea Company LimitedJugal Gupta and Navneet Gupta are mutual person
- Ramsai Tea Estates Private Limited
Jugal Gupta and Navneet Gupta are mutual person
- Gupta Tea Pvt Ltd
Jugal Gupta and Navneet Gupta are mutual person
- Sivanta Feeds Private Limited
Navneet Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ranbaxy Tradefin?
Unlock and access historical data on people associated with Ranbaxy Tradefin, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ranbaxy Tradefin, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranbaxy Tradefin's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
